“Simvastatin Treatment Reduces the Cholesterol Content of Membrane Lipid Rafts, Implicating the N -Methyl-D-Aspartate Receptor in Anxiety: A Literature Review”. Brazilian Journal of Pharmaceutical Sciences, vol. 53, no. 1, Jan. 2017, p. e16102-, https://doi.org/10.1590/s2175-97902017000116102.